Value of serum matrix metalloproteinase-3 in the assessment of active disease in patients with rheumatoid arthritis

To investigate the value of serum matrix metalloproteinase-3 (sMMP-3) in the assessment of active disease in patients with rheumatoid arthritis (RA). One hundred and ninety-one RA patients were recruited from the Department of Rheumatology of Sun Yat-sen Memorial Hospital from June 2010 to June 2014...

Full description

Saved in:
Bibliographic Details
Published inZhong hua yi xue za zhi Vol. 95; no. 47; p. 3823
Main Authors Ma, Jianda, Wang, Xiaoying, Mo, Yingqian, Chen, Lefeng, Zheng, Donghui, Wei, Xiuning, Dai, Lie
Format Journal Article
LanguageChinese
Published China 15.12.2015
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:To investigate the value of serum matrix metalloproteinase-3 (sMMP-3) in the assessment of active disease in patients with rheumatoid arthritis (RA). One hundred and ninety-one RA patients were recruited from the Department of Rheumatology of Sun Yat-sen Memorial Hospital from June 2010 to June 2014. sMMP-3 level of these RA patients and 58 healthy people was tested by enzyme-linked immunosorbent assay, while clinical data was collected simultaneously. Receiver operating characteristic (ROC) curve was used for the analysis of optimal cut-off point for the evaluation of disease activity. There were 128 female patients and 63 male patients recruited. sMMP-3 was significantly higher in RA patients than healthy control and it was higher in patients with active disease than that in patients in remission (all P < 0.01). ROC curve analysis showed that the optimal cut-off point for diagnosing active RA was 84 μg/L with area under the curve (AUC) 0.822 in female and 168 μg/L with AUC 0.824 in male (both P < 0.01). Acc
ISSN:0376-2491
DOI:10.3760/cma.j.issn.0376-2491.2015.47.006